Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions
NCT ID: NCT01073137
Last Updated: 2010-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
44 participants
OBSERVATIONAL
2006-06-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Glucose Monitoring System Clinical Study
NCT01327209
PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor
NCT02154126
Blood Glucose Testing and You
NCT01453413
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
NCT01175408
Biofeedback of Glucose in Non-diabetic Participants
NCT04077203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Up to five visits to the NCRAR will be needed over a six-month period to complete the study. Each visit lasts either two or four hours, and will be scheduled at your convenience. You will be paid $20 for the first 2-hour screening visit and $50 for each 4-hour visit. You will be paid $30 if you are selected to participate in a 2-hour Attention Correlation Test that a sub-set of 10 participants will complete.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic Subjects
No interventions assigned to this group
Non diabetic subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes
* Normal hearing
* Hemoglobin A1C of 5.5-8%
Exclusion Criteria
* visual impairment due to diabetic retinopathy
* organ failure (kidney, liver heart, or lungs)
* severe or unstable cardiovascular disease
* active alcohol or drug abuse
* schizophrenia
* bipolar disorder
* active major depressive disorder
* active foot ulcerations
* active viral or other infections such as HIV
* hepatitis, or pneumonia
* serious renal
* cardiac or cognitive dysfunction.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Portland VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oregon Health & Sciences University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric A Wan, PhD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Portland VA Medical Center
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.